Avaliação de massa tireoidiana

Última revisão: 22 Nov 2024
Última atualização: 28 Nov 2023

Resumo

Diagnósticos diferenciais

comuns

  • Nódulo coloide
  • Adenoma tireoidiano ou nódulo hiperplásico, único (sólido ou complexo)
  • Bócio multinodular não tóxico
  • Câncer de tireoide diferenciado (papilar, folicular)
Detalhes completos

Incomuns

  • Adenoma tóxico isolado
  • Bócio multinodular tóxico
  • Câncer medular de tireoide
  • Câncer anaplásico de tireoide
  • Linfoma
  • Cistos simples da tireoide revestidos por epitélio
  • Cisto do ducto tireoglosso
  • Tireoidite supurativa aguda
  • Tireoidite subaguda granulomatosa
  • Tireoidite linfocítica crônica (de Hashimoto)
  • Tireoidite linfocítica indolor
  • Doença de Graves
  • Glândula(s) paratireoide(s) aumentada(s): benigno
  • Carcinoma das paratireoides
  • Metástases para a tireoide de neoplasias malignas não tireoidianas
Detalhes completos

Colaboradores

Autores

Brendan C. Stack Jr, MD, FACS, FACE

Chairman, Endocrine Surgery Section

American Head and Neck Society

Professor and former inaugural Chairman

Department of Otolaryngology-Head and Neck Surgery

Southern Illinois University School of Medicine

Springfield

IL

Declarações

BCS is an author of a number of references cited in this topic.

Agradecimentos

Dr Brendan C. Stack would like to gratefully acknowledge Dr Steven P. Hodak and Dr Hussain Mahmud, the previous contributors to this topic.

Declarações

SPH and HM declare that they have no competing interests.

Revisores

Renee E. Amori, MD

Assistant Professor of Medicine

Division of Endocrinology

Drexel University College of Medicine

Philadelphia

PA

Declarações

REA declares that she has no competing interests.

Paul V. Carroll, MD, MRCPI, FRCP

Consultant Endocrinologist

Guy’s & St. Thomas’ NHS Foundation Trust

London

UK

Declarações

PVC declares that he has no competing interests.

Richard Bliss, MB, FRCS

Consultant Endocrine Surgeon

Newcastle Upon Tyne Hospitals NHS Trust

Newcastle

UK

Declarações

RB declares that he has no competing interests.

Haruko Akatsu, MD, MS

Clinical Associate Professor

Medical Director

Thyroid Cancer Program

Stanford University Medical Center

Stanford

CA

Declarações

HA declares that she has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal